Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack
OCT-RISK
Optical Coherence Tomography With Magnetic Resonance Angiography to Assess STEMI Non-culprit Risk
2 other identifiers
observational
90
1 country
2
Brief Summary
Heart attacks caused by the complete blockage of a heart artery are treated by opening it with a stent. However, most people will also have 'non-culprit' narrowings found in their other arteries at this time. Although in general people do better if these non-culprit narrowings are also treated with stents if they look severe, this process has problems. This is because narrowings that look severe may be stable and not cause any trouble. For these people a stent is a wasted procedure and unnecessary risk. On the other hand, narrowings that are currently left alone because they appear mild, may progress and cause a heart attack. Participants who have had a heart attack will have a scan from inside the heart arteries during an angiogram (optical coherence tomography, OCT) and a magnetic resonance angiogram (MRA). If the investigators can show that it is possible to accurately predict which non-culprit narrowings are going to progress and which are going to stabilise, medical professionals may be able to better target their treatments after a heart attack.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2023
CompletedFirst Posted
Study publicly available on registry
March 23, 2023
CompletedStudy Start
First participant enrolled
April 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2028
ExpectedSeptember 25, 2024
September 1, 2024
2.4 years
March 9, 2023
September 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in mean fibrous cap thickness measured by optical coherence tomography
6 months
Secondary Outcomes (3)
Change in mean lipid arc measured by optical coherence tomography
6 months
Presence of thin cap fibroatheroma measured by optical coherence tomography
6 months
Change in measures of shear stress made by optical coherence tomography and magnetic resonance angiography
0 and 6 months
Other Outcomes (2)
Non-culprit major adverse cardiac events
6 months and 36 months
Change in vessel stenosis measured by optical coherence tomography and magnetic resonance angiography
0, 6 and 36 months
Study Arms (1)
Standard of care
Patients after ST-elevation myocardial infarction with non-culprit coronary artery disease.
Interventions
Non-culprit coronary arteries
Eligibility Criteria
Patients after presentation with ST elevation myocardial infarction.
You may qualify if:
- Successful primary percutaneous coronary intervention (PCI) within the previous week with no major complications at the index procedure
- Bystander disease in a non-culprit vessel planned for clinically indicated staged angiography +/- PCI
- Able to provide written informed consent.
You may not qualify if:
- Cardiogenic shock requiring intubation, inotropes or a mechanical support device
- Creatinine clearance \<30ml/min
- Prior coronary artery bypass grafting
- Life expectancy less than 3 years
- Pregnancy.
- Target lesion in the left main coronary artery
- Severe calcification or tortuosity that would threaten safe placement of a pressure wire or OCT catheter
- Chronic total occlusion of a major epicardial vessel.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Guy's and St Thomas' NHS Foundation Trustlead
- King's College Londoncollaborator
- King's College Hospital NHS Trustcollaborator
Study Sites (2)
St Thomas' Hospital
London, SE1 7EH, United Kingdom
King's College Hospital
London, SE5 9RS, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Divaka Perera, MD
King's College London
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 9, 2023
First Posted
March 23, 2023
Study Start
April 25, 2023
Primary Completion
October 1, 2025
Study Completion (Estimated)
April 1, 2028
Last Updated
September 25, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share